Success Metrics

Clinical Success Rate
86.4%

Based on 19 completed trials

Completion Rate
86%(19/22)
Active Trials
9(24%)
Results Posted
0%(0 trials)
Terminated
3(8%)

Phase Distribution

Ph not_applicable
8
21%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
N/ANon-phased studies
8(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

79.2%

19 of 24 finished

Non-Completion Rate

20.8%

5 ended early

Currently Active

9

trials recruiting

Total Trials

38

all time

Status Distribution
Active(9)
Completed(19)
Terminated(5)
Other(5)

Detailed Status

Completed19
Recruiting5
unknown5
Active, not recruiting4
Terminated3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
38
Active
9
Success Rate
86.4%
Most Advanced
N/A

Trials by Phase

N/A8 (100.0%)

Trials by Status

completed1950%
recruiting513%
terminated38%
withdrawn25%
unknown513%
active_not_recruiting411%

Recent Activity

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more
NCT05196061

Human Skin and Gut Mycobiome and Bacteriome Comprehensive Registry

Recruiting
NCT05176795

Host-microbiota-environment Interactions

Terminated
NCT05794620

Faecal Microbiota Analysis in Neurotypical and Autism Syndrome Disorder Siblings

Completed
NCT03424915

Exercise, Fitness and Tumor Profiling in Breast Cancer Patients

Active Not Recruiting
NCT06801184

Single-center Exploratory Study of the Intestinal Microbiota in Patients Treated for Irritable Bowel Syndrome With Predominant Constipation and Methane Production

Recruiting
NCT04566029

Evolution of Proteomic Profiles of Intestinal Microbiota in Patients With Locally Advanced or Metastatic Urothelial Carcinomas

Completed
NCT05842343Not Applicable

Food Intake and IgA Microbiota in Anorexia Nervosa

Terminated
NCT06292598

Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control Population

Recruiting
NCT06616363

Does a Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Nat hx With Its Numerous Co-morbidities?

Recruiting
NCT04705662Not Applicable

GI Effects of Iron in Healthy Volunteers

Completed
NCT02728154

The Role of Gut Microbiota in Heart Failure and Pre-Heart Failure With Preserved Ejection Fraction

Withdrawn
NCT06302660

Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors

Active Not Recruiting
NCT05747651

3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erythematosus Study Protocol 2

Active Not Recruiting
NCT04584320

Identification of Clostridium Butyricum and Clostridium Neonatal in the Digestive Microbiota of Premature Infants Before 34 Weeks and Developing or Not Ulcerative Necrotizing Enterocolitis (NEC) During Hospitalization

Active Not Recruiting
NCT04245150

Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity

Completed
NCT02352389

A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents

Completed
NCT06143501

Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCT

Unknown
NCT03728699

Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy

Completed
NCT03557749

Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies

Terminated
NCT05234359

The CHILD Cohort COVID-19 Add-On Study

Completed

Drug Details

Intervention Type
OTHER
Total Trials
38